Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analyses
- Nat Commun. 2024 Feb 8;15(1):1163. doi: 10.1038/s41467-024-45366-0.
- 1. Research Center for Endocrine and Metabolic Disease, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- 2. Research Institute for Medical Sciences, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- 3. GENOME INSIGHT TECHNOLOGY Inc, Daejeon, Republic of Korea.
- 4. Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
- 5. Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- 6. Department of Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- 7. Department of Otolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
- 8. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- 9. Department of Surgery, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.
- 10. Department of Pathology, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- 11. Department of Biochemistry, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- 12. College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
- 13. Korea Research Institute of Bioscience and Biotechnology, Deajeon, Republic of Korea.
- 14. Department of Bioscience, University of Science and Technology (UST), Deajeon, Republic of Korea.
- 15. Korea Bioinformation Center (KOBIC), Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
- 16. Department of Nutrition, School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, China.
- 17. Department of Biochemistry, Chungnam National University, Daejeon, Republic of Korea.
- 18. Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.
- 19. Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, Los Angeles, USA.
- 20. Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
- 21. Korea Research Institute of Bioscience and Biotechnology, Deajeon, Republic of Korea. [email protected].
- 22. Research Institute for Medical Sciences, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. [email protected].
- 23. Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. [email protected].
- 24. Research Center for Endocrine and Metabolic Disease, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. [email protected].
- 25. Research Institute for Medical Sciences, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. [email protected].
- 26. Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. [email protected].
- # Contributed equally.
The role of the serine/glycine metabolic pathway (SGP) has recently been demonstrated in tumors; however, the pathological relevance of the SGP in thyroid Cancer remains unexplored. Here, we perform metabolomic profiling of 17 tumor-normal pairs; bulk transcriptomics of 263 normal thyroid, 348 papillary, and 21 undifferentiated thyroid Cancer samples; and single-cell transcriptomes from 15 cases, showing the impact of mitochondrial one-carbon metabolism in thyroid tumors. High expression of serine hydroxymethyltransferase-2 (SHMT2) and methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is associated with low thyroid differentiation scores and poor clinical features. A subpopulation of tumor cells with high mitochondrial one-carbon pathway activity is observed in the single-cell dataset. SHMT2 inhibition significantly compromises mitochondrial respiration and decreases cell proliferation and tumor size in vitro and in vivo. Collectively, our results highlight the importance of the mitochondrial one-carbon pathway in undifferentiated thyroid Cancer and suggest that SHMT2 is a potent therapeutic target.